Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesDevelopment of therapeutic HPV vaccines
The Lancet Oncology, 10/01/09
Trimble CL et al. – At least 15% of human malignant diseases are attributable to the consequences of persistent viral or bacterial infection. Chronic infection with oncogenic human papillomavirus (HPV) types is a necessary, but insufficient, cause in the development of more cancers than any other virus. Currently available prophylactic vaccines have no therapeutic effect for established infection or for disease. In this Review, the authors discuss recent progress in this field and priorities for future clinical investigations.
Related Articles
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Relevance Score: 72%
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/10/09
Relevance Score: 71%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 71%
Human papillomavirus vaccination in survivors of childhood cancer
Cancer, 10/12/09
Relevance Score: 71%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 71%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
DNA vaccines for biodefense
Expert Review of Vaccines, 12/08/09
Prospects for new plague vaccines
Expert Review of Vaccines, 12/08/09
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines
Expert Review of Vaccines, 12/08/09
Article Search
Sponsor